Hi kates,
News due Q1 2019:
-Travelan sales update (growth expected)
-NASH P2 study results, final report lodged with FDA
-C.diff trial enrollments completed and followed by results updates (its a short trial). Extremely positive results anticipated based on pre trial testing.
-Travelan FDA approval
So there is plenty of potentially positive news imminent.
- Forums
- ASX - By Stock
- Treatment for Clostridium-difficile Infection With IMM529
Hi kates, News due Q1 2019: -Travelan sales update (growth...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMC (ASX) to my watchlist
|
|||||
Last
8.1¢ |
Change
-0.007(7.95%) |
Mkt cap ! $18.46M |
Open | High | Low | Value | Volume |
8.0¢ | 8.2¢ | 8.0¢ | $14.34K | 178.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 72000 | 8.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.1¢ | 31515 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 72000 | 0.080 |
3 | 117996 | 0.079 |
2 | 37800 | 0.078 |
2 | 90000 | 0.077 |
1 | 13000 | 0.076 |
Price($) | Vol. | No. |
---|---|---|
0.081 | 31515 | 1 |
0.082 | 13219 | 1 |
0.083 | 24378 | 2 |
0.084 | 9888 | 1 |
0.089 | 10000 | 1 |
Last trade - 12.45pm 08/07/2024 (20 minute delay) ? |
Featured News
IMC (ASX) Chart |